Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E0E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,286
Award facts
- Contract value 100% obligated
- $50,285.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitive delivery order valued at $50,285.91 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units), with delivery to the company's corporate office location in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on December 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's extensive portfolio of federal contract awards encompasses a broad spectrum of pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, antibiotics, and specialized medical supplies. This specific delivery order for Jardiance, a diabetes medication, exemplifies the company's role in supplying brand-name pharmaceutical products to support federal healthcare operations and maintains consistency with AmerisourceBergen's established track record of competitively awarded, firm fixed-price delivery orders across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F4E0E?
SPE2DR26F4E0E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F4E0E worth?
The government has obligated $50,286 on SPE2DR26F4E0E.
Is contract SPE2DR26F4E0E an order under another contract?
Yes. SPE2DR26F4E0E is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E0E competed?
The extent of competition for SPE2DR26F4E0E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award